Macquarie Group’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$44.2M Buy
7,722,318
+907,236
+13% +$5.2M 0.05% 447
2025
Q1
$55.6M Buy
6,815,082
+187,060
+3% +$1.53M 0.07% 384
2024
Q4
$62.4M Sell
6,628,022
-341,857
-5% -$3.22M 0.08% 355
2024
Q3
$74.4M Sell
6,969,879
-151,343
-2% -$1.62M 0.08% 336
2024
Q2
$70.6M Buy
7,121,222
+50,489
+0.7% +$501K 0.08% 322
2024
Q1
$83.3M Sell
7,070,733
-144,277
-2% -$1.7M 0.09% 268
2023
Q4
$102M Buy
7,215,010
+2,358
+0% +$33.5K 0.12% 241
2023
Q3
$87.7M Buy
7,212,652
+290,671
+4% +$3.53M 0.11% 249
2023
Q2
$86.9M Sell
6,921,981
-249,054
-3% -$3.13M 0.1% 273
2023
Q1
$79.5M Buy
7,171,035
+212,988
+3% +$2.36M 0.09% 288
2022
Q4
$85M Buy
6,958,047
+80,286
+1% +$980K 0.1% 281
2022
Q3
$71.8M Buy
6,877,761
+110,515
+2% +$1.15M 0.09% 313
2022
Q2
$72.7M Buy
6,767,246
+224,367
+3% +$2.41M 0.08% 333
2022
Q1
$62K Buy
6,542,879
+248,193
+4% +$2.35K 0.05% 451
2021
Q4
$72.7M Sell
6,294,686
-71,898
-1% -$830K 0.06% 401
2021
Q3
$60.8M Buy
6,366,584
+77,743
+1% +$742K 0.05% 460
2021
Q2
$60.6M Buy
6,288,841
+594,646
+10% +$5.73M 0.05% 471
2021
Q1
$56.3M Buy
5,694,195
+2,407,160
+73% +$23.8M 0.08% 301
2020
Q4
$75.9M Buy
3,287,035
+2,543,281
+342% +$58.7M 0.11% 204
2020
Q3
$10.5M Buy
743,754
+618,632
+494% +$8.74M 0.02% 634
2020
Q2
$1.89M Sell
125,122
-23,448
-16% -$354K ﹤0.01% 1027
2020
Q1
$1.37M Buy
148,570
+8,068
+6% +$74.6K ﹤0.01% 1011
2019
Q4
$1.37M Buy
+140,502
New +$1.37M ﹤0.01% 1153